Up to the Minute: Onsite Insights From Clinical Osteoporosis 2010

Release date: March 2010
Expiration date: March 31, 2011
Estimated time to complete activity: 1 hour 15 minutes

Sponsored by
  

Support for this activity has been provided through an educational donation from

Activity Overview

The management of osteoporosis can be complicated by the availability of multiple therapeutic options, the often unrecognized and untreated occurrence of secondary causes of osteoporosis, and issues relating to the long-term treatment of patients with osteoporosis. The ISCD-NOF Clinical Osteoporosis 2010 meeting, which occurs on March 10-13, 2010 in San Antonio, Texas includes several educational sessions that address the challenges frequently encountered by clinicians who manage osteoporosis. The purpose of this activity is to provide clinicians who are unable to attend the meeting with a brief and timely summary of the clinically relevant points discussed during specific sessions and includes commentary from Nelson B. Watts, MD. The summaries will be posted on OsteoporosisTX.com within 48 hours of the date of the original presentation.

Target Audience

This activity has been designed to meet the educational needs of health care professionals in endocrinology, rheumatology, bone disease, obstetrics/gynecology, and primary care who manage patients who have or are at risk for osteoporosis.

Learning Objectives

Upon completion of this activity, participants should be able to:

• Identify and develop treatment strategies for patients with secondary osteoporosis
• Identify patients with osteoporosis who would receive optimal benefit from anabolic or biologic therapies
• Utilize the FRAX^® tool in daily practice
• Develop a management strategy for premenopausal women with osteoporosis
• Assess patient adherence and compliance in addition to the identification and use of strategies for the long-term management of patients receiving osteoporosis therapy

Faculty

Nelson B. Watts, MD
Professor of Medicine, University of Cincinnati College of Medicine
Director, University of Cincinnati Bone Health and Osteoporosis Center
Cincinnati, OH

Author

Thomas F. Finnegan, PhD
Medical Writer
Curatio CME Institute
Exton, PA

Disclosure

In accordance with the ACCME Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of everyone in a position to control content of an educational activity. A relevant financial relationship is a relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears below:

Nelson B. Watts, MD, has disclosed the following relevant financial relationship(s):

Speaker	Amgen, Novartis, Procter & Gamble, sanofi-aventis
Consultant	Amgen, Baxter, Eli Lilly, InteKrin, Johnson & Johnson, MannKind, Novartis, Novo Nordisk, Procter & Gamble, sanofi-aventis, Takeda Pharmaceuticals

Curatio CME Institute
Shari Dermer, PhD, Medical Director, has disclosed no relevant financial relationships.
Thomas F. Finnegan, PhD, Medical Writer, has disclosed no relevant financial relationships.
Adam J. Perahia, MD, Medical Writer, has disclosed no relevant financial relationships.
Jonathan S. Simmons, ELS, Managing Editor, has disclosed no relevant financial relationships.
Derek Warnick, CME Director, has disclosed no relevant financial relationships.

Accreditation Statement

Curatio CME Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

Physicians
Curatio CME Institute designates this educational activity for a maximum of 1.25 AMA PRA Category 1 Credit^™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nurse Practitioners
This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standards. This program is approved for 1.25 contact hours of continuing education by the American Academy of Nurse Practitioners. Program ID 1005165.

Method of Participation

There are no fees for participating in this CME activity. To receive credit during the period March 2010 to March 31, 2011, participants must (1) read the learning objectives and disclosure statements, (2) study the educational activity, and (3) complete the activity evaluation form, including the participation attestation statement.

Media

This activity will be offered as an Internet activity on OsteoporosisTX.com. Offering this CE activity online allows participants to learn on their own time and at their own pace.

Disclaimer

The information presented at this activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician regarding diagnosis and treatment of a specific patient's medical condition.

Unapproved Product Use

This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Curatio CME Institute and Amgen do not recommend the use of any agent outside the labeled indications.

The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Curatio CME Institute or Amgen. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Policy on Privacy and Confidentiality

Curatio CME Institute makes every effort to protect the privacy of OsteoporosisTX.com users; user information is used only to maintain records as required by the American Medical Association (AMA) and the ACCME.

Curatio CME Institute does not require individuals to register to use OsteoporosisTX.com; registration is only required for physicians, health care professionals, and other users to participate in and receive CME/CE credit for accredited educational programs hosted on OsteoporosisTX.com.

Curatio CME Institute is required by the AMA and the ACCME (and occasionally by other accrediting organizations) to collect user information that will allow Curatio CME Institute to issue a CME/CE certificate. Curatio CME Institute is required to keep this information on file for up to 6 years. The information is stored in a secure database and used only to verify individual participation in a CME/CE activity and to reissue a certificate if a user's original certificate is lost or misplaced.

Information gathered through OsteoporosisTX.com will not be released to any other company or organization for any purpose; this information remains confidential. At the end of the mandatory 6-year period, these records will be destroyed.

Curatio CME Institute uses Web site tracking software to determine how OsteoporosisTX.com is used. This information helps Curatio CME Institute determine the best strategies for improving OsteoporosisTX.com and better meeting the needs of its users. This software does not identify individual users.

OsteoporosisTX.com does not employ cookies or any other software that violates a user's privacy.

If you have any questions about OsteoporosisTX.com or any Curatio CME Institute policies, you may contact us at OsteoporosisTX@curatiocme.com.

Thank you for using OsteoporosisTX.com